Nicholas R. Rydzewski

998 total citations
19 papers, 521 citations indexed

About

Nicholas R. Rydzewski is a scholar working on Pulmonary and Respiratory Medicine, Cancer Research and Oncology. According to data from OpenAlex, Nicholas R. Rydzewski has authored 19 papers receiving a total of 521 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Pulmonary and Respiratory Medicine, 6 papers in Cancer Research and 4 papers in Oncology. Recurrent topics in Nicholas R. Rydzewski's work include Cancer Genomics and Diagnostics (4 papers), Radiomics and Machine Learning in Medical Imaging (3 papers) and Endometrial and Cervical Cancer Treatments (3 papers). Nicholas R. Rydzewski is often cited by papers focused on Cancer Genomics and Diagnostics (4 papers), Radiomics and Machine Learning in Medical Imaging (3 papers) and Endometrial and Cervical Cancer Treatments (3 papers). Nicholas R. Rydzewski collaborates with scholars based in United States, Sweden and Canada. Nicholas R. Rydzewski's co-authors include Qiong Gao, Xinran Li, Xiping Cheng, Haoxing Xu, Wuyang Wang, Junsheng Yang, Ahmad Hider, Xiaoli Zhang, Shuang G. Zhao and Jonathan Strauss and has published in prestigious journals such as Journal of Clinical Oncology, Nature Cell Biology and Cancer.

In The Last Decade

Nicholas R. Rydzewski

17 papers receiving 517 citations

Peers

Nicholas R. Rydzewski
Nazma Malik United Kingdom
Hideyuki Higashi United States
R. Quiles Spain
Peta Wood Australia
Nazma Malik United Kingdom
Nicholas R. Rydzewski
Citations per year, relative to Nicholas R. Rydzewski Nicholas R. Rydzewski (= 1×) peers Nazma Malik

Countries citing papers authored by Nicholas R. Rydzewski

Since Specialization
Citations

This map shows the geographic impact of Nicholas R. Rydzewski's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nicholas R. Rydzewski with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nicholas R. Rydzewski more than expected).

Fields of papers citing papers by Nicholas R. Rydzewski

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nicholas R. Rydzewski. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nicholas R. Rydzewski. The network helps show where Nicholas R. Rydzewski may publish in the future.

Co-authorship network of co-authors of Nicholas R. Rydzewski

This figure shows the co-authorship network connecting the top 25 collaborators of Nicholas R. Rydzewski. A scholar is included among the top collaborators of Nicholas R. Rydzewski based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nicholas R. Rydzewski. Nicholas R. Rydzewski is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Patel, Krishnan R., Nicholas R. Rydzewski, Holly Ning, et al.. (2024). A Phase 1 Trial of Salvage Stereotactic Body Radiation Therapy for Radiorecurrent Prostate Cancer After Brachytherapy. International Journal of Radiation Oncology*Biology*Physics. 119(5). 1471–1480. 2 indexed citations
2.
Rydzewski, Nicholas R., Deepak Dinakaran, Shuang G. Zhao, et al.. (2024). Comparative Evaluation of LLMs in Clinical Oncology. NEJM AI. 1(5). 56 indexed citations
3.
Rydzewski, Nicholas R., Yue Shi, Matthew R. Chrostek, et al.. (2024). A platform-independent AI tumor lineage and site (ATLAS) classifier. Communications Biology. 7(1). 314–314. 1 indexed citations
4.
Rydzewski, Nicholas R., et al.. (2023). Machine Learning & Molecular Radiation Tumor Biomarkers. Seminars in Radiation Oncology. 33(3). 243–251. 4 indexed citations
5.
Dinakaran, Deepak, et al.. (2023). 98 Radiosensitization of Glioblastoma Using Targeted Inhibition of N-Myristoylation. Radiotherapy and Oncology. 186. S46–S46. 1 indexed citations
6.
Patel, Krishnan R., Nicholas R. Rydzewski, Holly Ning, et al.. (2023). A Phase 1 Trial of Focal Salvage Stereotactic Body Radiation Therapy for Radiorecurrent Prostate Cancer. Practical Radiation Oncology. 13(6). 540–550. 6 indexed citations
7.
Rydzewski, Nicholas R., Meng Zhang, Arian Lundberg, et al.. (2022). Intrinsic Molecular Subtypes of Metastatic Castration-Resistant Prostate Cancer. Clinical Cancer Research. 28(24). 5396–5404. 9 indexed citations
8.
Helzer, Kyle T., Yeonhee Park, Yi Chen, et al.. (2022). Identification of phenocopies improves prediction of targeted therapy response over DNA mutations alone. npj Genomic Medicine. 7(1). 58–58. 5 indexed citations
9.
Rydzewski, Nicholas R., et al.. (2021). Radiomic Modeling of Bone Density and Rib Fracture Risk After Stereotactic Body Radiation Therapy for Early-Stage Non-Small Cell Lung Cancer. Advances in Radiation Oncology. 7(3). 100884–100884. 5 indexed citations
10.
Rydzewski, Nicholas R., Erik R. Peterson, Joshua M. Lang, et al.. (2021). Predicting cancer drug TARGETS - TreAtment Response Generalized Elastic-neT Signatures. npj Genomic Medicine. 6(1). 76–76. 16 indexed citations
11.
Rydzewski, Nicholas R., et al.. (2021). Immune-Depleted Phenotype in Non-Small Cell Lung Cancer Brain Metastases Predicts for Worse Overall Survival. International Journal of Radiation Oncology*Biology*Physics. 111(3). S14–S14.
12.
Rydzewski, Nicholas R., Paul M. Harari, Gregory K. Hartig, David M. Francis, & Matthew E. Witek. (2019). Clinical Implications of Scleroderma in the Decision for Radiotherapy-Based Larynx Preservation. JAMA Otolaryngology–Head & Neck Surgery. 146(3). 308–308. 3 indexed citations
13.
Rydzewski, Nicholas R., Margaux J. Kanis, Eric D. Donnelly, John R. Lurain, & Jonathan Strauss. (2018). Role of adjuvant external beam radiotherapy and chemotherapy in one versus two or more node-positive vulvar cancer: A National Cancer Database study. Radiotherapy and Oncology. 129(3). 534–539. 21 indexed citations
14.
Rydzewski, Nicholas R., Atif J. Khan, Jonathan Strauss, & Steven J. Chmura. (2018). Mortality After Stereotactic Radiosurgery for Brain Metastases and Implications for Optimal Utilization. American Journal of Clinical Oncology. 41(11). 1142–1147. 7 indexed citations
15.
Rydzewski, Nicholas R., Maciej S. Lesniak, James P. Chandler, et al.. (2017). Gross total resection and adjuvant radiotherapy most significant predictors of improved survival in patients with atypical meningioma. Cancer. 124(4). 734–742. 67 indexed citations
16.
Minami, Christina A., Karl Y. Bilimoria, Nora Hansen, et al.. (2016). National Evaluation of the New Commission on Cancer Quality Measure for Postmastectomy Radiation Treatment for Breast Cancer. Annals of Surgical Oncology. 23(8). 2446–2455. 5 indexed citations
17.
Li, Xinran, Nicholas R. Rydzewski, Ahmad Hider, et al.. (2016). A molecular mechanism to regulate lysosome motility for lysosome positioning and tubulation. Nature Cell Biology. 18(4). 404–417. 292 indexed citations
18.
Rydzewski, Nicholas R., Anna E. Strohl, Eric D. Donnelly, et al.. (2016). Receipt of vaginal brachytherapy is associated with improved survival in women with stage I endometrioid adenocarcinoma of the uterus: A National Cancer Data Base study. Cancer. 122(23). 3724–3731. 21 indexed citations
19.
Strohl, Anna E., Nicholas R. Rydzewski, Eric D. Donnelly, et al.. (2016). Use of adjuvant chemotherapy and radiation in women with node-positive endometrial cancer: A National Cancer Database study.. Journal of Clinical Oncology. 34(15_suppl). 5588–5588.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026